Correlation Between Vigil Neuroscience and OUTLOOK THERAPEUTICS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vigil Neuroscience and OUTLOOK THERAPEUTICS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vigil Neuroscience and OUTLOOK THERAPEUTICS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vigil Neuroscience and OUTLOOK THERAPEUTICS INC, you can compare the effects of market volatilities on Vigil Neuroscience and OUTLOOK THERAPEUTICS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vigil Neuroscience with a short position of OUTLOOK THERAPEUTICS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vigil Neuroscience and OUTLOOK THERAPEUTICS.

Diversification Opportunities for Vigil Neuroscience and OUTLOOK THERAPEUTICS

0.92
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Vigil and OUTLOOK is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Vigil Neuroscience and OUTLOOK THERAPEUTICS INC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OUTLOOK THERAPEUTICS INC and Vigil Neuroscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vigil Neuroscience are associated (or correlated) with OUTLOOK THERAPEUTICS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OUTLOOK THERAPEUTICS INC has no effect on the direction of Vigil Neuroscience i.e., Vigil Neuroscience and OUTLOOK THERAPEUTICS go up and down completely randomly.

Pair Corralation between Vigil Neuroscience and OUTLOOK THERAPEUTICS

Given the investment horizon of 90 days Vigil Neuroscience is expected to under-perform the OUTLOOK THERAPEUTICS. But the stock apears to be less risky and, when comparing its historical volatility, Vigil Neuroscience is 1.57 times less risky than OUTLOOK THERAPEUTICS. The stock trades about -0.12 of its potential returns per unit of risk. The OUTLOOK THERAPEUTICS INC is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest  709.00  in OUTLOOK THERAPEUTICS INC on September 30, 2024 and sell it today you would lose (508.00) from holding OUTLOOK THERAPEUTICS INC or give up 71.65% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Vigil Neuroscience  vs.  OUTLOOK THERAPEUTICS INC

 Performance 
       Timeline  
Vigil Neuroscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vigil Neuroscience has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
OUTLOOK THERAPEUTICS INC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OUTLOOK THERAPEUTICS INC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Vigil Neuroscience and OUTLOOK THERAPEUTICS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vigil Neuroscience and OUTLOOK THERAPEUTICS

The main advantage of trading using opposite Vigil Neuroscience and OUTLOOK THERAPEUTICS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vigil Neuroscience position performs unexpectedly, OUTLOOK THERAPEUTICS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OUTLOOK THERAPEUTICS will offset losses from the drop in OUTLOOK THERAPEUTICS's long position.
The idea behind Vigil Neuroscience and OUTLOOK THERAPEUTICS INC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation